Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C VanCott

Showing results (11-20 of 71) with videos related to

Pageof 8
Sort By:
Journal of Virology|April 10, 1999
Immunotyping of human immunodeficiency virus type 1 (HIV): an approach to immunologic classification of HIVS Zolla-Pazner, M K Gorny, P N Nyambi, et al.
Immunology and Cell Biology|October 14, 2004
Immunostimulatory CpG motifs induce CTL responses to HIV type I oligomeric gp140 envelope proteinMangala Rao, Gary R Matyas, Thomas C Vancott, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1995
Lack of induction of antibodies specific for conserved, discontinuous epitopes of HIV-1 envelope glycoprotein by candidate AIDS vaccinesT C VanCott, F R Bethke, D S Burke, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1994
Serum IgA-mediated neutralization of HIV type 1P R Burnett, T C VanCott, V R Polonis, et al.
Military Medicine|June 7, 2023
Prescribing Trends of Antiseizure Drugs in Women Veterans With EpilepsyMaria Raquel Lopez, Anne C VanCott, Megan E Amuan, et al.
Journal of Acquired Immune Deficiency Syndromes|November 1, 1994
Preferential antibody recognition of structurally distinct HIV-1 gp120 moleculesT C VanCott, F R Bethke, V Kalyanaraman, et al.
Immunology and Cell Biology|October 14, 2004
Liposome-stabilized oil-in-water emulsions as adjuvants: increased emulsion stability promotes induction of cytotoxic T lymphocytes against an HIV envelope antigenRoberta L Richards, Mangala Rao, Thomas C Vancott, et al.
Vaccine|March 4, 2000
Microparticles in MF59, a potent adjuvant combination for a recombinant protein vaccine against HIV-1D T O'Hagan, M Ugozzoli, J Barackman, et al.
AIDS Research and Human Retroviruses|November 1, 1995
Differential role of V3-specific antibodies in neutralization assays involving primary and laboratory-adapted isolates of HIV type 1T C Vancott, V R Polonis, L D Loomis, et al.
Journal of Clinical Microbiology|February 13, 1999
Application of dried blood spot specimens for serologic subtyping of human immunodeficiency virus type 1 in ThailandP Chanbancherd, A E Brown, R Trichavaroj, et al.
Pageof 8

Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
Journal of Virology|April 10, 1999
Immunotyping of human immunodeficiency virus type 1 (HIV): an approach to immunologic classification of HIVS Zolla-Pazner, M K Gorny, P N Nyambi, et al.
Immunology and Cell Biology|October 14, 2004
Immunostimulatory CpG motifs induce CTL responses to HIV type I oligomeric gp140 envelope proteinMangala Rao, Gary R Matyas, Thomas C Vancott, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1995
Lack of induction of antibodies specific for conserved, discontinuous epitopes of HIV-1 envelope glycoprotein by candidate AIDS vaccinesT C VanCott, F R Bethke, D S Burke, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1994
Serum IgA-mediated neutralization of HIV type 1P R Burnett, T C VanCott, V R Polonis, et al.
Military Medicine|June 7, 2023
Prescribing Trends of Antiseizure Drugs in Women Veterans With EpilepsyMaria Raquel Lopez, Anne C VanCott, Megan E Amuan, et al.
Journal of Acquired Immune Deficiency Syndromes|November 1, 1994
Preferential antibody recognition of structurally distinct HIV-1 gp120 moleculesT C VanCott, F R Bethke, V Kalyanaraman, et al.
Immunology and Cell Biology|October 14, 2004
Liposome-stabilized oil-in-water emulsions as adjuvants: increased emulsion stability promotes induction of cytotoxic T lymphocytes against an HIV envelope antigenRoberta L Richards, Mangala Rao, Thomas C Vancott, et al.
Vaccine|March 4, 2000
Microparticles in MF59, a potent adjuvant combination for a recombinant protein vaccine against HIV-1D T O'Hagan, M Ugozzoli, J Barackman, et al.
AIDS Research and Human Retroviruses|November 1, 1995
Differential role of V3-specific antibodies in neutralization assays involving primary and laboratory-adapted isolates of HIV type 1T C Vancott, V R Polonis, L D Loomis, et al.
Journal of Clinical Microbiology|February 13, 1999
Application of dried blood spot specimens for serologic subtyping of human immunodeficiency virus type 1 in ThailandP Chanbancherd, A E Brown, R Trichavaroj, et al.
Pageof 8